# Munther A. Khamashta

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/munther-a-khamashta/

## Facts

| Field | Value |
| --- | --- |
| Citations | 65,368 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 111 |
| i10-index | 431 |
| Last Known Institution | The King's College |
| OpenAlex ID | https://openalex.org/A5043181396 |
| ORCID iD | 0000-0002-8927-6024 |
| Works | 757 |

## Researcher papers

Showing 12 of 24.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop](https://scholariq.org/papers/international-consensus-statement-on-preliminary-classification-criteria-for/)
- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome](https://scholariq.org/papers/the-management-of-thrombosis-in-the-antiphospholipid-antibody-syndrome/)
- [Adult haemophagocytic syndrome](https://scholariq.org/papers/adult-haemophagocytic-syndrome/)
- [Immune-related adverse events of checkpoint inhibitors](https://scholariq.org/papers/immune-related-adverse-events-of-checkpoint-inhibitors/)
- [Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period](https://scholariq.org/papers/morbidity-and-mortality-in-systemic-lupus-erythematosus-during-a-10-year-period/)
- [EULAR recommendations for the management of antiphospholipid syndrome in adults](https://scholariq.org/papers/eular-recommendations-for-the-management-of-antiphospholipid-syndrome-in-adults/)
- [The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation](https://scholariq.org/papers/the-eular-points-to-consider-for-use-of-antirheumatic-drugs-before-pregnancy-and/)
- [Systemic lupus erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-3/)
- [Systemic Lupus Erythematosus](https://scholariq.org/papers/systemic-lupus-erythematosus-2/)
- [EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome](https://scholariq.org/papers/eular-recommendations-for-women-s-health-and-the-management-of-family-planning/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [The King's College](https://scholariq.org/institutions/the-king-s-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.